These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 27502068)

  • 41. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
    Li Y; Tan JQ; Mai ZY; Yang DZ
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
    [No Abstract]   [Full Text] [Related]  

  • 42. Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection.
    Polyzos NP; Tournaye H; Guzman L; Camus M; Nelson SM
    Fertil Steril; 2013 Aug; 100(2):430-7. PubMed ID: 23668992
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting the distribution of serum anti-müllerian hormone levels among infertile Asian women: a multi-nation, multi-centre, and multi-ethnicity prospective cohort study.
    Tzeng CR; Huang Z; Asada Y; Zhang C; Ho MT; Li RHW; Kim JH; Govindarajan M; Vuyavanich T; Sini I; Wong PS; Singh S; Lin WY; Ho NT
    Hum Reprod; 2023 Jul; 38(7):1368-1378. PubMed ID: 37105234
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
    Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
    Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of the lower serum anti-Müllerian hormone threshold for ovarian stimulation prior to in-vitro fertilization using the Elecsys® AMH assay: a prospective observational study.
    Grynnerup AG; Løssl K; Pilsgaard F; Lunding SA; Storgaard M; Bogstad JW; Prætorius L; Zedeler A; Bungum L; Nyboe Andersen A; Pinborg A
    Reprod Biol Endocrinol; 2019 Jan; 17(1):11. PubMed ID: 30634990
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa.
    Neves AR; Blockeel C; Griesinger G; Garcia-Velasco JA; Marca A; Rodriguez I; Drakopoulos P; Alvarez M; Tournaye H; Polyzos NP
    Reprod Biomed Online; 2020 Jul; 41(1):29-36. PubMed ID: 32466992
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
    Majumder K; Gelbaya TA; Laing I; Nardo LG
    Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of ovarian reserve markers in prediction of clinical pregnancy.
    Zebitay AG; Cetin O; Verit FF; Keskin S; Sakar MN; Karahuseyinoglu S; Ilhan G; Sahmay S
    J Obstet Gynaecol; 2017 May; 37(4):492-497. PubMed ID: 28421902
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AMH type II receptor and AMH gene polymorphisms are not associated with ovarian reserve, response, or outcomes in ovarian stimulation.
    Cerra C; Newman WG; Tohlob D; Byers H; Horne G; Roberts SA; Mohiyiddeen L
    J Assist Reprod Genet; 2016 Aug; 33(8):1085-91. PubMed ID: 27142041
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Different serum anti-Müllerian hormone concentrations are associated with oocyte quality, embryo development parameters and IVF-ICSI outcomes.
    Irez T; Ocal P; Guralp O; Cetin M; Aydogan B; Sahmay S
    Arch Gynecol Obstet; 2011 Nov; 284(5):1295-301. PubMed ID: 21748312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The association between anti-Müllerian hormone and IVF-ICSI outcome in poor responder patients performing long protocol.
    Aydin T; Kara M; Aran T; Turktekin N; Ozdemir B
    Clin Exp Obstet Gynecol; 2015; 42(5):663-5. PubMed ID: 26524819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. AFC vs. AMH: prediction of ovarian response in women with endometrioma undergoing controlled ovarian stimulation.
    Ersahin AA; Arpaci H; Ersahin SS; Celik N; Acet M
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2499-2503. PubMed ID: 28617534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The predictability of serum anti-Müllerian level in IVF/ICSI outcomes for patients of advanced reproductive age.
    Lee RK; Wu FS; Lin MH; Lin SY; Hwu YM
    Reprod Biol Endocrinol; 2011 Aug; 9():115. PubMed ID: 21843363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlations between anti-müllerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes.
    Cupisti S; Dittrich R; Mueller A; Strick R; Stiegler E; Binder H; Beckmann MW; Strissel P
    Eur J Med Res; 2007 Dec; 12(12):604-8. PubMed ID: 18024272
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-Mullerian hormone as a predictor of ovarian reserve in ART protocols: the hidden role of thyroid autoimmunity.
    Magri F; Schena L; Capelli V; Gaiti M; Zerbini F; Brambilla E; Rotondi M; De Amici M; Spinillo A; Nappi RE; Chiovato L
    Reprod Biol Endocrinol; 2015 Sep; 13(1):106. PubMed ID: 26391773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of anti-Müllerian hormone (AMH) on multiple pronuclei (PN) presence and oocyte maturity in ICSI treatments.
    Sayme N; Kljajic M; Krebs T; Maas DHA
    Gynecol Endocrinol; 2020 Jul; 36(7):646-649. PubMed ID: 31878804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.
    Ma S; Ma R; Xia T; Afnan M; Song X; Xu F; Hao G; Zhu F; Han J; Zhao Z
    Trials; 2018 Feb; 19(1):124. PubMed ID: 29458401
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between AMH, oocyte number and availability of embryos for cryopreservation in IVF.
    Kotanidis L; Asimakopoulos B; Nikolettos N
    In Vivo; 2013; 27(6):877-80. PubMed ID: 24292596
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Female age, serum antimüllerian hormone level, and number of oocytes affect the rate and number of euploid blastocysts in in vitro fertilization/intracytoplasmic sperm injection cycles.
    La Marca A; Minasi MG; Sighinolfi G; Greco P; Argento C; Grisendi V; Fiorentino F; Greco E
    Fertil Steril; 2017 Nov; 108(5):777-783.e2. PubMed ID: 28987789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.